|
PRTA
|
Prothena Corporation plc
|
0.12%
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
0.12%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.11%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
LYEL
|
Lyell Immunopharma, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.11%
|
US
|
NASDAQ
|
|
VERV
|
Verve Therapeutics, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
SIGA
|
SIGA Technologies Inc.
|
0.10%
|
US
|
NASDAQ
|
|
SANA
|
Sana Biotechnology, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.10%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
0.10%
|
CA
|
TSX
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|